Keywords: sandoz, il-3, shows, promise, cancer, reported, its

SANDOZ' IL-3 SHOWS PROMISE IN CANCER

Article | 14 June 1993

Print This

Sandoz has reported that its recombinant interleukin-3 or multi-CSF product, either alone or in combination with other cytokines, could allow ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in